These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23239688)
21. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
22. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter? Kanematsu M Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455 [No Abstract] [Full Text] [Related]
23. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis. Park YS; Lee CH; Kim BH; Lee J; Choi JW; Kim KA; Ahn JH; Park CM Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409 [TBL] [Abstract][Full Text] [Related]
25. Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver. Weishaupt D; Willmann JK; Lutz AM; Marincek B Eur Radiol; 2004 Jan; 14 Suppl 1():C5-6. PubMed ID: 15113059 [No Abstract] [Full Text] [Related]
26. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis. Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909 [TBL] [Abstract][Full Text] [Related]
27. Proper definitions of MRI contrast enhancement in liver tumors. Ni Y; Chen F; Wang H; Feng Y; Li J; Jiang Y J Gastroenterol; 2010 Mar; 45(3):349-50; author reply 351-2. PubMed ID: 20012916 [No Abstract] [Full Text] [Related]
28. [Differentiation of focal liver lesions using contrast-enhanced MRT]. Heintz P; Ehrenheim C Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880 [TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient. Hammerstingl R; Zangos S; Schwarz W; Rosen T; Bechstein WO; Balzer T; Vogl TJ Acad Radiol; 2002 May; 9 Suppl 1():S119-20. PubMed ID: 12019845 [No Abstract] [Full Text] [Related]
31. Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Awaya H; Ito K; Honjo K; Fujita T; Matsumoto T; Matsunaga N Clin Imaging; 1998; 22(3):180-7. PubMed ID: 9559229 [TBL] [Abstract][Full Text] [Related]
32. Hepatobiliary and Pancreatic: Focal peliosis hepatis mimicking hepatocellular carcinoma in a hepatitis B carrier. Lai WJ; Chiu NC; Chau GY J Gastroenterol Hepatol; 2016 Jun; 31(6):1073. PubMed ID: 26600454 [No Abstract] [Full Text] [Related]
33. Correction to The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver. Br J Radiol; 2016 Oct; 89(1066):20150117e. PubMed ID: 27572243 [No Abstract] [Full Text] [Related]
34. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA. Jung G; Breuer J; Poll LW; Koch JA; Balzer T; Chang S; Mödder U Acta Radiol; 2006 Feb; 47(1):15-23. PubMed ID: 16498928 [TBL] [Abstract][Full Text] [Related]
40. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. Di Pietropaolo M; Briani C; Federici GF; Marignani M; Begini P; Delle Fave G; Iannicelli E Clin Imaging; 2015; 39(3):468-75. PubMed ID: 25748089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]